Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome

Journal of Internal Medicine

Volumn 247, Issue 6, 2000, Pages 667-673

  Coiro, Vittorio ^a   Volpi, R ^a   Capretti, L ^b   Caffarri, G ^c   Chiodera, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Hospital of Codogno   (Italy)

^c Hospital of Guastalla   (Italy)

Author keywords

Alcohol; Cushing syndrome; Desmopressin; Hexarelin

Indexed keywords

ALCOHOL; CORTICOTROPIN; DESMOPRESSIN; DEXAMETHASONE; HEXARELIN; HYDROCORTISONE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING DISEASE; CUSHINGOID SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIFFERENTIAL DIAGNOSIS; HOT FLUSH; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOLISM; CUSHING SYNDROME; DEAMINO ARGININE VASOPRESSIN; ETHANOL; FEMALE; HUMANS; HYDROCORTISONE; MALE; OLIGOPEPTIDES; PITUITARY NEOPLASMS; RADIOIMMUNOASSAY; SINGLE-BLIND METHOD;

EID: 0033935946     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00676.x     Document Type: Article

References (21)

1. 1 Lamberts SWJ, Klijn JGM, De Jong FH, Birkenhäger JC. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing's disease. J Am Med Ass 1979; 242: 1640-13.
2. 2 Kapkala L. Alcohol-induced pseudo-Cushing's syndrome mimicking Cushing's disease in a patient with adrenal mass. Am J Med 1987; 82: 849-56.
3. 3 Kirkman S, Nelson DH. Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism 1988; 37: 339-94.
4. 4 Cook DM. Alcohol-induced pseudo-Cushing's syndrome. Endocrinologist 1994; 4: 160-6.
5. 5 Malerbi DA, Mendonça BB, Liberman B, Toledo SPA, Corradini MCM, Cunha-Neto MB, et al. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol 1993; 38: 463-72.
6. 6 Colombo P, Passini E, Re T, Fraglia G, Ambrosi B. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol 1997; 46: 661-7.
7. 7 Ghigo E, Arvat E, Ramunni J, Coalo A, Giannotti L, Deghenghi R, et al. Adrenocorticotropin-and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and in patients with Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 2439-44.
8. 8 Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, et al. A combined test using desmopressin and corticotropion releasing hormone in the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 176-81.
9. 9 Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM III R patients, Version (SCID-P). New York, USA: Biometrics Research Department, New York Psychiatric Institute, 1988; p. 42.
10. 10 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
11. 11 Cobb C, Thiel DH, Gavaler JS, Lester R. Effects of ethanol and acetaldehyde on the rat adrenal. Metabolism 1981; 30: 537-43.
12. 12 Ellis F. Effect of ethanol on plasma corticosterone levels. J Pharmacol Exp Ther 1966; 153: 121-8.
13. 13 Rivier C, Bruhn T, Vale W. Effect of ethanol on the hypothalamic-pituitary axis in the rat: role of CRH. J Pharmacol Exp Ther 1984; 229: 127-31.
14. 14 Redei E, Branch BJ, Gholami S, Lin EYR, Taylor AN. Effects of ethanol on CRF release in vitro. Endocrinol 1988; 123: 2736-43.
15. 15 Wand G, Froehlich J. Alterations in hypothalamo-hypophyseal function by ethanol. In: .McCleod R, Müller EE, eds. Neuroendocrine perspectives. New York, USA: Springer-Verlag, 1990; 45-122.
16. 16 Baertschi AJ, Friedli M. A novel type of vasopressin receptor in anterior pituitary corticotrophs? Endocrinol 1985; 116: 499-502.
17. 17 Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinol 1984; 114: 1537-45.
18. 18 Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K. Conformation energy studies and in vitro and in vivo activity data on active GH releasing peptides. Endocrinol 1984; 114: 1531-6.
19. 19 Arvat E, De Vito L, Macacgno B, Broglio F, Boghen MF, Deghenghi R, et al. Effects of GHRF-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in men. Comparison with the effects of GHRH, TRH and hCRH. Peptides 1997; 18: 885-91.
20. 20 Hickey GJ, Drisko J, Faidley T, Chang C, Anderson L, Nicolich S, et al. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692, 585. J Endocrinol 1996; 148: 371-80.
21. 21 Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 1991; 72: 1290-5.